Skip to main content
. 2015 Apr 1;17(4):283–290. doi: 10.1089/dia.2014.0234

FIG. 2.

FIG. 2.

Changes in body weight and glycated hemoglobin (HbA1c) in obese Chinese type 2 diabetes patients implanted with a gastric contractility modulator (TANTALUS II) (solid circles) stratified by baseline plasma triglyceride (TG), compared with the insulin treatment group (open squares): (1a and 1b) body weight and (2a and 2b) HbA1c between the insulin group and (1a and 2a) the low TG TANTALUS group or (1b and 2b) the high TG TANTALUS group. The P value represents the estimated difference by repeated-measures analysis of variance (rANOVA).